Printer Friendly

Browse Hemophilia topic

Articles

1-300 out of 600 article(s) nextnext page
Title Author Type Date Words
The Service On The Implementation Of Organizational Measures Related To The Provision Of Persons With Drugs Intended For The Treatment Of Patients With Hemophilia, Cystic Fibrosis, Pituitary Nanism, Gaucher Disease, Lymphoid, Hematopoietic And Related Tis. Jul 13, 2019 168
Sigilon Therapeutics Presents Data Demonstrating Feasibility of Shielded Living Therapeutics Platform for Hemophilia A at ISTH 2019 Congress. Jul 12, 2019 341
Provision Of Services For Acceptance, Storage, Delivery To Pharmacies And Delivery Of Drugs Intended For The Treatment Of Patients With Hemophilia, Cystic Fibrosis, Pituitary Nanism, Gaucher Disease, Lymphoid Neoplasms, Hematopoietic And Related Tissues,. Jul 12, 2019 148
Switzerland : Roche presents a broad range of data for Hemlibra demonstrating continued benefits for people with haemophilia A at the ISTH 2019 Congress. Jul 12, 2019 860
BRAIN TEST HORROR; Blood inquiry told of invasive surgery after boy dies. Jul 12, 2019 243
Genentech Presents a Broad Range of Data for Hemlibra Demonstrating Continued Benefits for People with Hemophilia A at the ISTH 2019 Congress. Jul 12, 2019 1376
Acquiring Drugs Thalassemia Haemophilia Program (romania-braov: Medicinal Products For The Blood, Blood-forming Organs And The Cardiovascular System). Jul 11, 2019 165
Logan and Lisa give charity a PS1.2k thank you. Jul 11, 2019 505
Lives 'devastated' by tainted transfusions; Inquiry: Wife of haemophiliac shares hour-long testimony. Jul 10, 2019 650
BioMarin weakness 'a buying opportunity' ahead of Q4 catalysts, says Wedbush. Jul 10, 2019 134
Recombinant Plasma Protein Therapeutics Market Analyzed for the Projected Period of 2018 -- 2026. Jul 10, 2019 1084
Recombinant Plasma Protein Therapeutics Market Analyzed for the Projected Period of 2018 -- 2026. Jul 10, 2019 1071
Recombinant Plasma Protein Therapeutics Market Analyzed for the Projected Period of 2018 -- 2026. Jul 10, 2019 1071
Pfizer and Sangamo reveal details of phase 1/2 Alta study of SB-525 haemophilia A gene therapy. Jul 9, 2019 203
Pfizer and Sangamo reveal details of phase 1/2 Alta study of SB-525 haemophilia A gene therapy. Jul 9, 2019 199
Takeda Release New Data from the PROPEL Study at ISTH 2019, Reinforcing the Potential Benefit for Personalised Prophylaxis with Adynovate in Severe Hemophilia A. Clinical report Jul 9, 2019 394
Octapharma Present New Data on the Benefits of Nuwiq In Patients with Haemophilia A. Jul 9, 2019 659
Swedish Orphan Biovitrum AB updates results of MIND study in people with haemophilia. Jul 8, 2019 343
ISTH reports first of its kind global education in haemophilia. Jul 8, 2019 289
The International Society on Thrombosis and Haemostasis launches Gene Therapy in Hemophilia. Jul 8, 2019 168
ISTH reports first of its kind global education in haemophilia. Jul 8, 2019 285
The International Society on Thrombosis and Haemostasis launches Gene Therapy in Hemophilia. Jul 8, 2019 164
Catalyst Biosciences Phase 2 trial of MarzAA met primary endpoint. Jul 8, 2019 126
Novo Nordisk says concizumab showed favorable safety profile in Phase 2 studies. Jul 8, 2019 141
BioMarin plans to submit marketing applications for valoctocogene roxaparvovec. Jul 8, 2019 106
Fly Intel: Pre-market Movers. Jul 8, 2019 294
Coagulation Factor IX Market Perceptions Targeting Industrial Expansion Studied during the Forecast. Jul 8, 2019 819
Swedish Orphan Biovitrum AB announces interim results from verITI-8 study of Elocta for Immune Tolerance Induction for severe haemophilia A with inhibitors. Clinical report Jul 8, 2019 367
Swedish Orphan Biovitrum AB updates results of MIND study in people with haemophilia. Jul 8, 2019 347
Swedish Orphan Biovitrum AB announces interim results from verITI-8 study of Elocta for Immune Tolerance Induction for severe haemophilia A with inhibitors. Clinical report Jul 8, 2019 363
Sangamo, Pfizer announce updated Phase 1/2 Alta study results for SB-525. Jul 7, 2019 304
uniQure announces follow-up data from Phase IIb study of AMT-061, AMT-060. Jul 7, 2019 589
Coagulation Factor IX Market Perceptions Targeting Industrial Expansion Studied during the Forecast. Jul 7, 2019 805
Conclusion Of A Contract Pursuant To Section 130a (8) Sentence 5 Sgb V/Section 130c (1) Sgb V On Medicines For The Specific Therapy Of Coagulation Disorders In Hemophilia. Jul 5, 2019 203
Man kept in the dark over blood infection. Jul 5, 2019 419
Blood scandal records 'missing'. Jul 4, 2019 228
Tearful dad tells how son died of Aids; Blood scandal: Records 'destroyed'. Jul 4, 2019 350
Hemophilia Gene Therapy Market Scenario Focusing on Improvements Shaping Industry Growth. Jul 4, 2019 882
Hemophilia Gene Therapy Market Scenario Focusing on Improvements Shaping Industry Growth. Jul 4, 2019 867
Hemophilia Gene Therapy Market Investigation & Industry Evolution till 2028. Jul 4, 2019 867
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) - BioMarin Announces Acceptance of Late Breaking Abstract at the International Society on Thrombosis and Haemostasis (ISTH) 2019 Congress in Melbourne, Australia from July 6-10, 2019 -- 26/6/2019. Jul 4, 2019 312
Concentrate Of Recombinant Coagulation Factor Ix Of The 2nd Generation Minimum; Proceedings Sign: Zzp-144/19;. Jul 3, 2019 513
Mum accuses docs in blood scandal probe. Jul 3, 2019 221
'My brother's grave was defaced... we were branded the AIDS family'. Jul 3, 2019 347
United States : Sangamo Announces Upcoming Presentation Of Investigational SB-525 Hemophilia A Gene Therapy Data At ISTH 2019. Jun 22, 2019 244
Novo Nordisk receives EU marketing authorisation for Esperoct. Jun 21, 2019 198
Novo Nordisk receives EU marketing authorisation for Esperoct. Jun 21, 2019 199
Novo Nordisk receives EU marketing authorisation for Esperoct. Jun 21, 2019 194
Transfusion victim's '36-year nightmare' LIFE BLIGHTED BY HEPATITIS. Jun 21, 2019 1075
United States : Inslee, health care leaders, patients kick off nations first public option health care effort. Jun 20, 2019 189
Inquiry told of man's hepatitis C bombshell. Jun 14, 2019 273
Man lost four of his brothers in NHS infected blood scandal. Jun 13, 2019 589
Coagulation Factor IX Market Investigation and Growth Forecasted Until the End of 2026. Jun 12, 2019 819
Coagulation Factor IX Market Investigation and Growth Forecasted Until the End of 2026. Jun 12, 2019 805
Inquiry told 'stigmatising' medical bags left outside widow's home. Jun 12, 2019 1495
Vandals defaced my brother's grave and threw stones at it... MAN TELLS INFECTED BLOOD INQUIRY OF FAMILY'S HELL. Jun 12, 2019 579
BioMarin hemophilia A potential larger than anticipated, says Cantor Fitzgerald. Jun 10, 2019 102
Roche. Jun 1, 2019 139
Evaluation of Unfavorable Cardiovascular and Metabolic Risk Factors in Children and Young Adults with Haemophilia. Yildiz, Melek; Ozdemir, Nihal; Onal, Hasan; Koc, Basak; Tipici, Beyza Eliuz; Zulfikar, Bulent Jun 1, 2019 5292
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) - BioMarin Announces that Phase 3 Cohort of Valoctocogene Roxaparvovec, Gene Therapy Study in Severe Hemophilia A Met Pre-Specified Criteria for Regulatory Submissions in the U.S. and Europe -- 28/5/2019. May 29, 2019 617
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) - BioMarin Provides 3 Years of Clinical Data from Ongoing Phase 1/2 Study of Valoctocogene Roxaparvovec Gene Therapy for Severe Hemophilia A -- 28/5/2019. May 29, 2019 1541
BioMarin: valoctocogene roxaparvovec met pre-specified criteria for review. May 28, 2019 561
BioMarin: valoctocogene roxaparvovec met pre-specified criteria for review. May 28, 2019 561
BioMarin says valoctocogene roxaparvovec bleed control maintained for third year. May 28, 2019 265
Chief Secretary lauds services of Hamza Foundation Hospital. May 27, 2019 259
CS applauds HFWH for serving blood genetic disorder patients. May 27, 2019 252
Infected blood victim asked wife to kill him; Widow tells inquiry of 'gentle giant's' torment; Respected teacher's hellish final days revealed. May 25, 2019 637
LIVES ARE STILL BEING LOST TO INFECTED BLOOD; Sufferer tells probe of pain. May 22, 2019 391
Supply Divided Into 2 Lots Of Analytical Systems For Blood Tests Required For The University Hospital Of Sassari (italy-sassari: Diagnostic Systems). May 17, 2019 195
uniQure's AMT-061 looking 'clearly superior' to competition, says Piper Jaffray. May 12, 2019 134
PM criticised for scandal response; UK & WORLD. May 11, 2019 174
PM criticised for scandal response; UK & WORLD. May 11, 2019 174
uniQure presents updated Phase 2b AMT-061 data at HTRS. May 10, 2019 357
E-tender For The Procurement Of Anti-haemophilia Drugs For The Year 2019-20. May 10, 2019 148
Coagulation Factor IX Market to Deliver Prominent Growth & Striking Opportunities during 2018-2026. May 9, 2019 805
Coagulation Factor IX Market to Deliver Prominent Growth & Striking Opportunities during 2018-2026. May 9, 2019 777
Coagulation Factor IX Market to Deliver Prominent Growth & Striking Opportunities during 2018-2026. May 9, 2019 819
Health Ministry sends 15 truckloads of medical supplies to Gaza. May 8, 2019 131
Give us justice, says father in blood scandal. May 4, 2019 321
Give us justice, says father in blood scandal. May 4, 2019 321
'Haemophilia injections'. May 2, 2019 266
Valrox could become BioMarin's largest product, says Jefferies. May 2, 2019 149
Infected blood victim 'arranged funeral in hospital'. May 1, 2019 157
Infected blood victim 'arranged funeral in hospital'. May 1, 2019 158
Adaptive Biotechnologies Names Baldo as Chief Medical Officer. Apr 30, 2019 317
Novo Nordisk announces receipt of positive opinion from CMPH for Esperoct for the treatment of haemophilia A in Europe. Apr 29, 2019 220
Novo Nordisk announces receipt of positive opinion from CMPH for Esperoct for the treatment of haemophilia A in Europe. Apr 29, 2019 216
Coagulation Factor IX Market Projects Greater Demand Owing to Higher Contribution by Leading Players. Apr 29, 2019 781
Cantor continues to see 'highly favorable' risk/reward on BioMarin shares. Apr 26, 2019 108
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN). Apr 25, 2019 2243
United States : St. Jude Childrens Research Hospital and the World Federation of Hemophilia announce collaboration. Apr 20, 2019 489
'Voluntary blood donation can help haemophilia patients'. Apr 19, 2019 464
Medical expert calls for 'public awareness' on World Hemophilia Day. Apr 18, 2019 451
HWSK marks 'World Haemophilia Day'. Apr 18, 2019 485
New multidisciplinary clinic improving care for patients with haemophilia. Apr 17, 2019 857
Recombinant Protein Therapy Market: Toxicity Screening, and Drug Discovery Will Witness the Fastest. Apr 15, 2019 768
uniQure says six data presentations to be delivered at ASGCT. Apr 15, 2019 111
Logan faces a lifetime of injections ... but brave tot takes it in his stride; Youngster diagnosed with haemophilia at six months. Apr 13, 2019 547
Capital police to arrange blood for thalassaemia centre. Apr 13, 2019 374
Thalassemia test at district's hospitals being considered: DC. Apr 11, 2019 182
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN). Apr 11, 2019 2243
Inspirational mum helps son to shine. Apr 10, 2019 245
Hemophilia awareness seminar on April 17. Apr 10, 2019 162
Hemophilia awareness seminar on April 17. Apr 10, 2019 136
United States : Sangamo Provides Clinical Development Update Including Early Phase 1/2 Beta Thalassemia Gene-edited Cell Therapy Data. Apr 5, 2019 867
United States : Sangamo and Pfizer Announce Phase 1/2 Interim Data for Investigational Hemophilia A Gene Therapy. Apr 5, 2019 799
Sangamo Therapeutics and Pfizer reveal interim data from haemophilia Phase 1/2 Alta study. Apr 4, 2019 283
Sangamo Therapeutics and Pfizer reveal interim data from haemophilia Phase 1/2 Alta study. Apr 4, 2019 279
Seminar on Hemophilia on April 17. Apr 4, 2019 115
Sangamo, Pfizer Release Phase 1/2 Interim Data for Investigational Hemophilia A Gene Therapy. Apr 3, 2019 702
Sangamo, Pfizer announce Phase 1/2 interim data for SB-525 gene therapy. Apr 2, 2019 392
Fly Intel: Pre-market Movers. Apr 2, 2019 226
Sangamo price target raised to $34 from $24 at Wells Fargo. Apr 2, 2019 135
Catalyst Biosciences receives orphan drug desgination for MarzAA in EU. Apr 1, 2019 202
Tender For Supply Of Anti Haemophilia Drugs, Kdl/ad/anti Haemophilia/10/2018-19. Mar 31, 2019 104
Understanding Hemophilia for All Ages. Mar 28, 2019 606
19/08-1 Drugs Affecting Blood Formation And Blood (coagulation Factor Viii) For Patients Under The Age Of 18 Years. Mar 26, 2019 168
Hemophilia Gene Therapy Market Comprehensive Analysis of World Markets & Trade, 2028. Mar 21, 2019 1044
Coagulation Factor IX Market Value Projected to Expand by 2026. Mar 21, 2019 1184
Hemophilia Gene Therapy Market to Record an Exponential CAGR by 2028. Mar 21, 2019 1017
Coagulation Factor IX Market Expansion Projected to Gain an Uptick During 2018 to 2026. Mar 21, 2019 1157
The European Commission approves Roche's haemophilia drug Hemlibra. Mar 15, 2019 162
The European Commission approves Roche's haemophilia drug Hemlibra. Mar 15, 2019 158
Roche announces EC approval of Hemlibra. Mar 14, 2019 145
Sangamo announces publication of ZFN data in Nature Communications. Mar 8, 2019 151
UoS blood camp for thalassemia patients. Mar 7, 2019 264
GLASGOW IS STANDOUT PERFORMER IN EVENTS BOOM. Mar 5, 2019 2136
Blood diseases treatment centers may rise: official. Mar 3, 2019 226
BM Group supports World Hemophilia Day 2019. Feb 28, 2019 311
Coagulation Factor IX Market Dynamics, Forecast, Analysis and Supply Demand 2018-2026. Feb 26, 2019 843
Coagulation Factor IX Market size and Key Trends in terms of volume and value 2018-2026. Feb 26, 2019 828
Cantor sees uniQure as next gene therapy buyout, ups price target to $81. Feb 25, 2019 103
Roche may spark another bull run for gene therapy names, says Credit Suisse. Feb 25, 2019 132
CHOOSING SMART EMBRYOS ISN'T IMMORAL. Bailey, Ronald Feb 21, 2019 675
Novo Nordisk announces approval of Biologics License Application for ESPEROCT by US FDA. Feb 20, 2019 308
Novo Nordisk announces approval of Biologics License Application for ESPEROCT by US FDA. Feb 20, 2019 304
uniQure announces updated data on Phase 2b AMT-061 trial. Feb 8, 2019 370
Catalyst Biosciences presents interim FVIIa data at EAHAD. Feb 8, 2019 300
Takeda Show Results from First-of-Its-Kind Phase IIIb/IV Trial PROPEL a Randomized PK-Guided Prophylaxis Study Evaluating Higher Factor VIII Levels in Hemophilia Aat EAHAD 2019. Clinical report Feb 7, 2019 335
Report: Jury orders Takeda to pay Bayer $155M over hemophilia drug. Perry, Jessica Brief article Feb 6, 2019 241
Catalyst study results show four-fold reduction in bleeding time for CB 2679d-GT. Feb 6, 2019 192
uniQure announces first patient treated in HOPE-B trial of AMT-061. Feb 4, 2019 178
Chugai's Hemlibra Gains Positive CHMP Opinion in Severe Hemophilia a Without Inhibitors. Feb 4, 2019 296
Roche says CHMP recommends EU approval of Hemlibra. Feb 1, 2019 183
Purchase Of Hemophilia Drugs. Jan 15, 2019 154
Supply Of Hemophilia Factors And Medicines For Thalassemia Patients. Dec 14, 2018 156
United States : Genentechs Hemlibra (emicizumab-kxwh) Provided Sustained Bleed Control in the Largest Pivotal Study to Date of Children With Hemophilia A With Factor VIII Inhibitors. Dec 10, 2018 618
Helping poorly children feel better with MOMENTS OF MAGIC; hospital launches PS75,000 christmas campaign. Dec 7, 2018 815
Nhs Framework Agreement For The Supply Of Recombinant Factor Ix Products For The Treatment Of Haemophilia B. Dec 7, 2018 102
At ASH, Extended Half-Life Therapies Eloctate and Alprolix Demonstrate Proven Efficacy and Well-Characterised Safety over Four Years. Dec 4, 2018 569
Belgium : Data from patient registries to replace clinical trials in previously untreated haemophilia patients. Dec 4, 2018 304
uniQure announces updated AMT-060 results, AMT-061 update at ASH. Financial report Dec 3, 2018 248
Genentech's Hemlibra provided sustained bleed control in pivotal study. Dec 3, 2018 258
Catalyst announces positive data from Phase 2/3 study of Marzeptacog Alfa. Dec 2, 2018 302
Global Cryoprecipitated Antihemophilic Factor Market Expected to Secure Notable Revenue Share during. Nov 19, 2018 333
Spark Therapeutics upgraded to Neutral from Underperform at Credit Suisse. Nov 16, 2018 162
On The Fly: Top five analyst upgrades. Nov 16, 2018 230
uniQure announces data from dose-confirmation study of AMT-061. Nov 15, 2018 417
JPMorgan downgrades Sangamo to Neutral on 'growing skepticism'. Nov 14, 2018 105
Physiotherapeutic Rehabilitation And Evaluation Services For Hemophilia Patients. Nov 14, 2018 205
Single father of 5 kids suffering from rare blood disorder. Nov 12, 2018 242
Now Adam has a garda and angel; Mum praises blood disorder lad's caring twin Grace. Nov 11, 2018 673
Sangamo says SMC recommends hemophilia A study continue with higher dose. Nov 9, 2018 238
Sangamo downgraded to Neutral after Hemophilia A 'about-face' at Guggenheim. Nov 9, 2018 116
Spark Therapeutics upgraded to Neutral on valuation at Wedbush. Nov 7, 2018 127
Spark Therapeutics price target lowered to $48 from $60 at BMO Capital. Nov 7, 2018 110
Medicines For Haemophilia (romania-braov: Medicinal Products For The Blood And Blood-forming Organs). Nov 4, 2018 154
Anti-hemophilia Factor And Thalassemia Drugs Anti Hemophilic Factor Viii With Von Willcbrand's Factor,activate Prothrombin Complex Concentrate (injections). Nov 3, 2018 168
Pseudotumor hemofilico de fosa posterior como forma de presentacion de hemofilia en paciente pediatrico. Reporte de caso y revision. Villalpando-Navarrete, Edgar; Garcia-Mendez, Antonio; Lara-Torres, Hector Ricardo Estudio de caso Nov 1, 2018 1060
Anti-hemophilia Factor And Thalassemia Drugs Anti Hemophilic Factor Viii With Von Willcbrand's Factor,activate Prothrombin Complex Concentrate (injections). Oct 29, 2018 166
Aptevo Therapeutics announces updated growth strategy for Ixinity. Oct 24, 2018 152
BioMarin price target raised to $125 from $118 at Jefferies. Oct 16, 2018 105
Novo Nordisk names Ludovic Helfgott as new executive vice president Biopharm. Oct 15, 2018 208
Novo Nordisk names Ludovic Helfgott as new executive vice president Biopharm. Oct 15, 2018 209
Hemophilia Treatment Drugs Market Size, Share, Emerging Trends, Analysis and Forecasts to 2024. Oct 15, 2018 146
Rendering In 2018 A Service Related To The Maintenance Of The High-cost Nosology Software Complex. Oct 14, 2018 151
Students donate blood to thalassaemia patients. Oct 12, 2018 409
uniQure risk/reward 'increasingly favorable' into R&D day, says H.C. Wainwright. Oct 11, 2018 122
18/10-1 Drug That Affects Blood And Blood (coagulation Factor Viii). Oct 11, 2018 141
US Food and Drug Administration approves Roche's Hemlibra. Oct 8, 2018 180
US Food and Drug Administration approves Roche's Hemlibra. Oct 8, 2018 176
Roche's Genentech announces FDA approval of Hemlibra for Hemophilia A. Oct 4, 2018 147
FAST FACTS. Oct 1, 2018 158
Save One Life. Hopewell, Martha Oct 1, 2018 399
Valuable Foresights on How Home Infusion Therapy Services Market will Grow During 2017-2025. Sep 26, 2018 240
Hemophilia disease. Sep 18, 2018 156
Shire granted EU marketing authorization for Veyvondi. Sep 12, 2018 120
Maintenance Of Software And Hardware Complex "trastmed" As Part Of The Management Of The Register Of Citizens In Seven High-cost Nosology (hemophilia, Cystic Fibrosis, Pituitary Dwarfism, Gaucher Disease, Malignant Neoplasms Of Lymphoid, Haematopoietic An. Sep 9, 2018 190
18/09-1 Drugs Affecting Hemopoiesis And Blood (coagulation Factor Ix For Patients With Hemophilia Before The Age Of 7 Years). Sep 8, 2018 133
Germany : Bayer receives US approval for modern hemophilia A treatment Jivi with a step-wise prophylaxis dosing regimen. Sep 5, 2018 287
USFDA approves Jivi for hemophilia A patients. Sep 4, 2018 135
USFDA approves Jivi for hemophilia A patients. Sep 4, 2018 131
Catalyst Biosciences announces publication of MarzAA Phase 1 data. Sep 4, 2018 202
Bayer passes US FDA's approval for Jivi for the routine prophylactic treatment of hemophilia A. Sep 3, 2018 331
Bayer passes US FDA's approval for Jivi for the routine prophylactic treatment of hemophilia A. Sep 3, 2018 327
Bayer wins US FDA approval for Jivi for the routine prophylactic treatment of haemophilia A patients. Aug 31, 2018 299
Bayer wins US FDA approval for Jivi for the routine prophylactic treatment of haemophilia A patients. Aug 31, 2018 295
Positive Phase III Results for Genentech's Hemlibra (emicizumab-kxwh) for Hemophilia A Without Factor VIII Inhibitors Published in New England Journal of Medicine. Aug 31, 2018 139
Switzerland : Positive phase III results for Roches Hemlibra for haemophilia A without factor VIII inhibitors published in New England Journal of Medicine. Aug 31, 2018 267
Genentech Phase III HAVEN 3 study results published in NEJM. Aug 30, 2018 211
Medicines For Haemophilia (romania-braov: Medicinal Products For The Blood And Blood-forming Organs). Aug 23, 2018 145
Help International Trust to hold 'ijtimai qurbani' on Wednesday. Aug 22, 2018 178
PROFILE OF HAEMOPHILIA PATIENTS IN MANIPUR. Singh, Irom Anil; Ginzaniang, T.; Devi, P. Vedanti; Singh, A. Meina; Singh, N. Dhanachand; Yoihenba, Report Aug 13, 2018 2896
Spark Therapeutics price target lowered to $77 from $91 at Mizuho. Aug 8, 2018 121
Spark Therapeutics selloff on hemophilia A data overdone, says Barclays. Aug 8, 2018 102
Sangamo's candidate for Hemophilia A shows positive Phase 1/2 safety data. Aug 8, 2018 154
Spark sinks after mean hemophilia study dose response comes in at 30%. Aug 7, 2018 129
BioMarin competitive positioning 'improved measurably,' says Piper Jaffray. Aug 7, 2018 118
Citi upgrades Spark Therapeutics to Buy with shares down nearly 30%. Aug 7, 2018 174
New Platform May Someday Treat A Variety Or Genetic Diseases. Aug 6, 2018 412
New Platform May Someday Treat A Variety Of Genetic Diseases. Aug 6, 2018 412
Supplies And Services. Aug 6, 2018 121
Pharmacokinetic Studies of Factor VIII in Chinese Boys with Severe Hemophilia A: A Single-Center Study. Chen, Zhen-Ping; Li, Pei-Jing; Li, Gang; Tang, Ling; Zhen, Ying-Zi; Wu, Xin-Yi; Cheng, Xiao-Ling; Lu Report Aug 5, 2018 3917
New Platform May Someday Treat A Variety Of Genetic Diseases. Jul 30, 2018 412
Germany : Bayer receives approval for Kovaltry in China for the treatment of children and adults with Hemophilia A. Jul 27, 2018 155
UnitedHealthcare, Aetna fined by DOBI. Calio, Vince Brief article Jul 23, 2018 259
Pfizer Initiates Phase 3 Lead-in Study of Hemophilia B Gene Therapy. Jul 19, 2018 354
I think of Pete every day. I have not been able to move on in my life because there has been no justice; PLEA FROM WIDOW OVER INQUIRY INTO NHS BLOOD SCANDAL. Jul 5, 2018 768
Give us justice, demands blood scandal widow. Jul 4, 2018 753
The High Purity Viii Treatment For Treatment Of Haemophilia A From Foreign Plasma For The Treatment Of Congenital Haemorrhage Factor Concentrate. Jun 24, 2018 161
Catalyst Biosciences provides update on CB 2679d/ISU304 Factor IX program. Jun 18, 2018 307
United States : FDA Grants Priority Review to Genentechs HEMLIBRA (emicizumab-kxwh) for People With Hemophilia A Without Factor VIII Inhibitors. Jun 11, 2018 220
CJP visits PIMS, expresses satisfaction over hospital's service delivery system. Jun 6, 2018 512
Expresses satisfaction over hospital's service delivery system. Jun 6, 2018 512
CJP visits PIMS, expresses satisfaction on health facilities. Jun 6, 2018 506
CJP visits PIMS, expresses satisfaction over hospital's service delivery system. Jun 5, 2018 503
Switzerland : FDA grants Priority Review to Roches Hemlibra for people with haemophilia A without factor VIII inhibitors. Jun 5, 2018 212
HowdoIsay thank you? By climbing a volcano... Jun 1, 2018 681
CSL Behring passes US FDA's approval for IDELVION in new 3500 IU Vial for treating hemophilia B. Jun 1, 2018 274
CSL Behring passes US FDA's approval for IDELVION in new 3500 IU Vial for treating hemophilia B. Jun 1, 2018 270
Zach needed specialist help - now family is saying thank you; Zachery Conroy has just turned one when he was diagnosed with haemophilia which needs specialist treatment. May 30, 2018 705
uniQure issued new patents covering methods of treating coagulopathies. May 29, 2018 237
Chugai Achieves Positive Results in Two Phase lll Studies of Bispecific Antibody Hemlibra. Clinical report May 25, 2018 270
Bioverativ Factor VIII Therapy Demonstrates Half-life of 37 hours with High Factor VIII Activity Following Single Low Dose. May 24, 2018 246
Blood-borne diseases increasing: Dr. Naeem. May 24, 2018 105
Blood-borne diseases increasing: Dr. Naeem. May 24, 2018 105
BioMarin 'raised efficacy bar' with valrox Phase 3 modification, says Jefferies. May 22, 2018 108
Roche's Hemlibra decreases bleeding in hemophilia patients in two phase three Haven studies. May 22, 2018 205
Roche's Hemlibra decreases bleeding in hemophilia patients in two phase three Haven studies. May 22, 2018 201
Spark Therapeutics, Pfizer announce data SPK-9001 ongoing Phase 1/2 trial. May 22, 2018 227
BioMarin updates results from Phase 1/2 study of valoctocogene roxaparvovec. May 22, 2018 107
BioMarin hemophilia A data remain 'intriguing,' says Evercore ISI. May 22, 2018 104
BioMarin weakness on valrox data a buying opportunity, says Piper Jaffray. May 22, 2018 112
Spark Therapeutics should not be higher on BioMarin data, says Citi. May 22, 2018 118
uniQure says new data demonstrates favorable immunogenicity profile of AAV5. May 21, 2018 465
Roche's Hemlibra sees positive results in Phase III HAVEN 3 study. May 21, 2018 225
Roche's Hemlibra sees positive results in Phase III HAVEN 3 study. May 21, 2018 221
Dusit's new center of excellence. May 20, 2018 1243
Provision Of Bypassing Agents For The Treatment Of Haemophilia With Inhibitors. May 18, 2018 103
BioMarin doses first patient in in a Phase 1/2 study evaluating valoctocogene. May 15, 2018 128
Supply Of Drugs Hemophilia. May 12, 2018 173
Philippines : HAZUR exists to help hemophiliacs. May 8, 2018 564
Help the HAPLOS Community. Apr 29, 2018 540
55 haemophilia patients visited HMC facilities last year. Apr 27, 2018 396
Experts emphasizes role of society for catering needs of patients with blood-borne diseases. Apr 25, 2018 479
More than 50,000 thalassemic patients in country. Apr 25, 2018 278
Blood donation camp held in Dolphin Headquarters. Apr 24, 2018 103
Biogen sees 'significant' opportunity for future growth of Spinraza worldwide. Apr 24, 2018 134
Help the HAPLOS Community. Apr 22, 2018 510
Bioverativ Celebrates World Hemophilia Day with Stories of Impact of Hemophilia Treatment. Apr 20, 2018 219
Hemophilia advocates express support for bill seeking creation of treatment centers. Apr 20, 2018 547
Brittle, broken. Apr 20, 2018 397
Magellan Rx Management Provides Results from Hemophilia Management Program. Apr 19, 2018 405
Genentech Garners Breakthrough Therapy Designation for Hemlibra (emicizumab-kxwh) in Hemophilia A without Factor VIII Inhibitors. Apr 19, 2018 260
US FDA grants breakthrough therapy designation to Roche's Hemlibra. Apr 19, 2018 245
US FDA grants breakthrough therapy designation to Roche's Hemlibra. Apr 19, 2018 241
Fragile as glass, strong as iron. Apr 18, 2018 771
55 young haemophilia patients admitted to HMC in 2017: Official. Apr 18, 2018 599
Doctor urge public to be aware of Hemophilia disease. Apr 18, 2018 492
HMC: Understanding Hemophilia Symptoms Will Lead to Better Management of the Disorder. Disease/Disorder overview Apr 18, 2018 696
Lawmaker wants support for people with bleeding disorders. Apr 17, 2018 246
Awareness campaign on world hemophilia day. Apr 17, 2018 241
What Is World Hemophilia Day? Facts To Know About Rare Disease. Apr 17, 2018 611
Kyrgyzstan joins global hemophilia program of World Federation of Hemophilia. Apr 16, 2018 159
'World Haemophilia Day' to be observed on April 17. Apr 12, 2018 125
Catalyst Biosciences says Korean MFDS approves sixth cohort of CB 2679d trial. Apr 12, 2018 112
World Haemophila Day on April 17. Apr 10, 2018 138
Treatment centers for bleeding disorders needed. Apr 8, 2018 313
Seminar to be held at Hemophilia Day on April 17. Apr 5, 2018 223
Implementation Of Organizational Measures To Provide Citizens With Medicines Intended For The Treatment Of Patients With Malignant Neoplasms Of Lymphoid, Hematopoietic And Related Tissues, Hemophilia, Cystic Fibrosis, Pituitary Abscess, Gaucher Disease, M. Apr 1, 2018 167
Terapia secuencia!; una opcion en el paciente hemofilico que no responde a! manejo con monoterapia con agentes puente, estudio observaciona! de! GrHeCol (Grupo Hemofilia Colombia). Casas, Claudia Patricia; Sossa, Claudia Lucia; Linares, Adriana; Omana-Orduz, Olga Paola; Pena, Ange Apr 1, 2018 3705
Experiencias de mujeres frente al cuidado de hijos diagnosticados con hemofilia. Casas, Claudia Patricia; Hernandez, Sonia Milena; Solano, Maria Helena; Castiblanco, Ruth Alexandra; Apr 1, 2018 6156
A Rare Seen Hemorrhage Disorder: Factor XI Deficiency Hemophilia C/Nadir Gorulen Bir Kanama Bozuklugu: Faktor XI Eksikligi Hemofili C. Ozer, Samet; Kazanci, Nafia Ozlem; Sonmezgoz, Ergun; Unuvar, Seyma; Akbulut, Nihat Apr 1, 2018 1947
Contaminated blood victims to receive funds. Mar 30, 2018 525
Blood scandal families' legal advice funded. Mar 30, 2018 428
Shire investors may be amenable to $50B-plus bid, says Jefferies. Mar 29, 2018 103
Chugai receives favourable ruling in patent infringement lawsuit. Mar 28, 2018 177
Chugai receives favourable ruling in patent infringement lawsuit. Mar 28, 2018 173
Still considerable value in Shire even in no Takeda bid scenario, says BofA/Merrill. Mar 28, 2018 125
Provision Of Social Services For The Implementation Of Organizational Activities Related To Providing Citizens With Medicinal Products Intended For The Treatment Of Patients With Malignant Neoplasms Of Lymphoid, Hematopoietic And Related Tissues, Hemophil. Mar 25, 2018 165
Japan : Anti-Coagulation Factor IXa/X Humanized Bispecific Monoclonal Antibody HEMLIBRA Subcutaneous Injection Approved in Japan. Mar 24, 2018 607
First ever surgery for hemophilia patient performed in Kyrgyzstan. Mar 22, 2018 118
Philippines : Villanueva seeks passage of 'standard of care' bill for patients with bleeding disorders. Mar 22, 2018 536
Philippines : Sen. Joel Villanueva's opening remarks during the Senate health committee hearing on bleeding disorder bills. Mar 22, 2018 663
Ibnsina Pharma signs contracts with Novo Nordisk to distribute products in Egypt. Mar 21, 2018 381
Thief who stole five city charity boxes is jailed. Mar 19, 2018 439
Experts join overseas fight against disease. Mar 14, 2018 509
Experts join overseas fight against disease; BLOOD SPECIALISTS LOOKING TO HELP PATIENTS IN INDIA. Mar 14, 2018 467
France : Sanofi Completes Acquisition of Bioverativ Inc. Mar 10, 2018 343
114 children suffer from hemophilia in Kyrgyzstan. Mar 1, 2018 119

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters